FDA Inspection 1238058 — Changxing Pharmaceutical Co., Ltd.
The FDA completed an inspection of Changxing Pharmaceutical Co., Ltd. on Apr 22, 2024 in Huzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 22, 2024
- Fiscal Year
- 2024
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Huzhou (China)
Citations
| ID | CFR | Description |
|---|---|---|
| 18149 | 21 CFR 117.40 | Equipment and utensils - Design and maintenance |
| 18163 | 21 CFR 117.80(c)(8) | Process control - Foreign objects |